For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Performance & Growth Hormone · Comparison

Deslorelin vs Sermorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

DeslorelinSermorelin
CategoryPerformance & Growth HormonePerformance & Growth Hormone
Also known asSuvaPryn, Ovuplant, D-His6-Pro9-Et-GnRHGHRH 1-29, GRF 1-29 NH2, Geref
EvidenceResearch-stageFDA-approved
Dosing range50mcg–200mcg mcg, Daily SC for continuous suppression; single or short course for pituitary reset100mcg–500mcg mcg, once daily (before sleep)
AdministrationSubcutaneous implant (veterinary), Subcutaneous injectionSubcutaneous injection
Key side effectsHot flashes, Bone density loss (prolonged suppression), Suppression of testosterone or estrogen, Mood changes, irritabilityInjection site redness, Headache, Flushing, Dizziness
Cited sources2 references1 reference

Key differences

  • Evidence level differs: Deslorelin is research-stage, while Sermorelin is fda-approved.
  • Administration: Deslorelin — Subcutaneous implant (veterinary), Subcutaneous injection; Sermorelin — Subcutaneous injection.
  • Frequency: Deslorelin is typically Daily SC for continuous suppression; single or short course for pituitary reset; Sermorelin is once daily (before sleep).
  • Research depth: this profile cites 2 sources for Deslorelin vs 1 for Sermorelin.

How each works

Deslorelin

Deslorelin produces a robust initial LH/FSH surge (flare effect) followed by profound, sustained pituitary desensitization with continued exposure. This biphasic response is consistent across all high-affinity GnRH super agonists. The flare phase is exploited for reproductive timing in veterinary medicine; the desensitization phase creates the clinical suppression used in precocious puberty and research HPG axis reset protocols.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full Deslorelin profileRead the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.